Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 2 results out of 2
Data Insights
Risk adjusted net present value: What is the current valuation of Arbutus Biopharma's Imdusiran Sodium?
Imdusiran Sodium is an antisense rnai oligonucleotide commercialized by Arbutus Biopharma, with a leading Phase II program in Hepatitis B....
Data Insights
Risk adjusted net present value: What is the current valuation of Arbutus Biopharma's Imdusiran Sodium?
Imdusiran Sodium is an antisense rnai oligonucleotide commercialized by Arbutus Biopharma, with a leading Phase II program in Hepatitis B....